1. Aisner SC, Finkelstein DM, Ettinger DS, et al. The clinical significance of variantmorphology small-cell carcinoma of the lung. J Clin Oncol 1990;8:402–408.
2. Ariyoshi Y, Fukuoka M, Furuse K, et al. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group. Jpn J Clin Oncol 1994;24:275–281.
3. Arriagada R, Le Chevalier T, Pignon JP, et al. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 1993;329:1848–1852.
4. Arriagada R, Le Chevalier T, Ruffie P, et al. Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center’s Lung Group. Int J Radiat Oncol Biol Phys 1990;19:1135–1138.
5. Arriagada R, Pellae-Cosset B, Cueto Ladron de Guevara JC, et al. Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences. Radiother Oncol 1991;20:91–98.